Third-party tests found over 70 vials of the antivenom for soldiers would be needed to treat bites from some snakes The US army spent nearly $1m (£750,000) last year on anti-snake venom drugs for troops, which evidence suggests may have weak efficacy. The two drugs do not appear to have undergone any independent testing for safety or effectiveness, an investigation has found, despite evidence that the civilian version of one of the drugs tested had weak efficacy.
US army spends $1m on anti-snake venom drugs without independent testing
The Guardian - 22 May 2025 15:35
Third-party tests found over 70 vials of the antivenom for soldiers would be needed to treat bites from some snakes The US army spent nearly $1m (£750,000) last year on anti-snake venom drugs for troops, which evidence suggests may have weak efficacy. The two drugs do not appear to have undergone any independent testing for safety or effectiveness, an investigation has found, despite evidence that the civilian version of one of the drugs tested had weak efficacy.
Share this Article
Recommended